Akèy › Fatig
Etid klinik pou Fatig ap rekrite nan Etazini
59 etid pou Fatig ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Baltimore, MD8 etid
- Houston, TX7 etid
- New York City, NY7 etid
- Charlotte, NC6 etid
- Nashville, TN5 etid
- Birmingham, AL5 etid
- Seattle, WA4 etid
- Cincinnati, OH4 etid
- Miami, FL4 etid
- Dallas, TX3 etid
- Los Angeles, CA3 etid
- Macon, GA3 etid
- Sugar Land, TX3 etid
- Reading, PA3 etid
- Austin, TX3 etid
- Columbia, SC3 etid
- Orlando, FL3 etid
- Madison, WI3 etid
- San Antonio, TX3 etid
- Boulder, CO3 etid
- Farmington Hills, MI3 etid
- Pittsburgh, PA3 etid
- Boston, MA3 etid
- Charleston, SC3 etid
- Spokane, WA3 etid
- Atlanta, GA3 etid
- Philadelphia, PA3 etid
- Morgantown, WV3 etid
- Peoria, AZ3 etid
- League City, TX3 etid
- Chicago, IL3 etid
Pa eta
- Alabama7 etid
- Arizona7 etid
- Colorado4 etid
- Florid9 etid
- Georgia5 etid
- Illinois6 etid
- Indiana4 etid
- Kalifòni6 etid
- Kansas4 etid
- Lwizyàn3 etid
- Maryland8 etid
- Massachusetts4 etid
- Michigan9 etid
- Missouri5 etid
- New Jersey3 etid
- New York11 etid
- North Carolina7 etid
- Ohio5 etid
- Oklahoma4 etid
- Pennsylvania6 etid
- South Carolina4 etid
- Tennessee6 etid
- Texas12 etid
- Washington7 etid
- West Virginia3 etid
- Wisconsin5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07151677Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07621809A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437Cardiac Output and Fatigue in Friedreich's Ataxia
Ap rekrite
Tout laj · Tout sèks · Mizajou Sep 22, 2026 · NCT07444333Natural History Study of Mitochondrial Myopathy
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 100 · Tout sèks · Mizajou Sep 17, 2026 · NCT05250375A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07500090Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue
Ap rekriteFaz 2
Laj 34 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT05584124C-Protein in Fatigue and Aging
Ap rekriteVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 9, 2026 · NCT05926219A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07455383Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07014111A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07675135Near-Infrared Spectroscopy, Acute Taurine Supplementation, and Isolated Muscular Endurance and Fatigue Resistance in Young Healthy Adults
Ap rekriteVolontè an sante akeyi
Laj 18 a 40 · Tout sèks · Mizajou Aug 26, 2026 · NCT07654946Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06978127Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Ap rekrite
Laj 6 ak plis · Gason · Mizajou Aug 17, 2026 · NCT07766980Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
Ap rekrite
Laj 18 a 39 · Tout sèks · Mizajou Aug 12, 2026 · NCT07186556Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Aug 10, 2026 · NCT07180537Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06634381Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT07581080Telephone Support in Advanced Gastrointestinal Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT06532877Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT07554443Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
Ap rekrite
Laj 50 a 94 · Tout sèks · Mizajou Jun 23, 2026 · NCT05977179Training in Evidence-based Treatments in Psycho-Oncology
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05674357Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Jun 9, 2026 · NCT06170970Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 5, 2026 · NCT06482515Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 5, 2026 · NCT06614309Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.